Question · asked by 1 review
Flutamide 250 mg once to b.i.d. vs spironolactone 100 mg: Change in health‐related quality of life (HRQOL) ‐ not measured
- Population
- women with hirsutism
- Intervention
- Flutamide 250 mg once to b.i.d.
- Comparison
- spironolactone 100 mg
- Outcome
- Change in health‐related quality of life (HRQOL) ‐ not measured
The review found no eligible studies for this question.
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Flutamide 250 mg once to b.i.d. vs spironolactone 100 mg Change in health‐related quality of life (HRQOL) ‐ not measured · women with hirsutism The review found no eligible studies for this question. Interventions for hirsutism (excluding laser and photoepilation therapy alone) (2015) · Cochrane Headline outcomes only | no estimate extracted | Not reported | No studies found |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for hirsutism (excluding laser and photoepilation therapy alone) 2015 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Flutamide 250 mg once to b.i.d. vs metformin 1275 mg to 1700 mg per day · women with hirsutism · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.